reported a significantly increased risk for carriers of this allele [odds ratio (OR) = 1.4] 74, many epidemiological studies have been conducted to reveal an association between the HER‐2 655V polymorphism and an increased risk of breast cancer 31. Here, ERBB2 is linked to breast carcinoma.